Filing Details
- Accession Number:
- 0001209191-21-025201
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-05 17:00:45
- Reporting Period:
- 2021-04-01
- Accepted Time:
- 2021-04-05 17:00:45
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1610950 | Syneos Health Inc. | SYNH | Services-Commercial Physical & Biological Research (8731) | 273403111 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1624073 | Alistair Macdonald | C/O Syneos Health, Inc. 1030 Sync Street Morrisville NC 27560 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Acquisiton | 2021-04-01 | 17,398 | $40.12 | 231,907 | No | 4 | M | Direct | |
| Class A Common Stock | Disposition | 2021-04-01 | 673 | $76.11 | 231,234 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2021-04-01 | 13,720 | $77.61 | 217,514 | No | 4 | S | Direct | |
| Class A Common Stock | Disposition | 2021-04-01 | 3,005 | $77.92 | 214,509 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class A Common Stock | Stock Option (Right to Buy Class A Common Stock) | Disposition | 2021-04-01 | 17,398 | $0.00 | 17,398 | $40.12 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-06-30 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 30, 2020.
- The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $75.84 to $76.81, inclusive. The reporting person undertakes to provide Syneos Health, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $76.87 to $77.86, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $77.87 to $78.10, inclusive. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The shares subject to this option vested in four approximately equal annual installments on June 30, 2016; June 30, 2017; June 30, 2018; and June 30, 2019.
Billionaire Hedge Funds
